2m 2m 2m 2m 2m 2m 2m
Sarepta Therap (SRPT)
NASDAQ
$17.28+$0.02 (+0.12%)
Price as of Jun 23, 2026 7:50 PM EDT- $1.9BMarket Cap
- -6.47%1-Year Change
- BiotechnologyIndustry
Sarepta Therap (SRPT)
$17.28+$0.02 (+0.12%)
SRPT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.26 | ||
Change | +$0.12 (+0.68%) | ||
Open | $17.33 | ||
High | $17.80 | ||
Low | $17.22 | ||
Previous Close | $17.65 | ||
Volume | 2,371,699 | ||
30-Day Average Volume | 3,021,428 | ||
1-Week Change | 11.92% | ||
1-Month Change | 5.06% | ||
1-Year Change | -6.47% | ||
3-Year Change | -85.76% | ||
5-Year Change | -77.83% | ||
Fundamentals | |||
Shares Outstanding | 105.6M | ||
Total Assets | $3.2B | ||
Market Cap | $1.9B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $730.8M | ||
Net Income | $331.0M | ||
Free Cash Flow | -$204.8M | ||
EBIT | $364.9M | ||
EBITDA | $375.5M | ||
Net Working Capital | $1.8B | ||
EPS | $2.88 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | 6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue